Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic neurotransmission and cognitive decline in velocardiofacial syndrome
2006-006203-36Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metyrosine in Dementia and Velocardiofacial syndrome (VCFS) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Metabolite levels after acute AMPT challenge and Metabolite levels after 4 weeks of AMPT treatment. Started Jun 2008; status: active.
02
Drugs
metyrosine
03
Conditions
DementiaVelocardiofacial syndrome (VCFS)
Beyond the preview
Go deeper on 2006-006203-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006203-36.